Table 10.

Association of risk factors with hepatotoxicity at 2 months of antituberculosis therapy

Factors	Subgroup	Number (%) of patients		P‐value
		No hepatotoxicity	Hepatotoxicity
Treatment Group	Control	54 (93.10)	4 (6.90)	0.026a
	Test	48 (100.00)	0 (0.00)
Age (years)	18–30	28 (90.32)	3 (9.68)	0.210
	31–40	39 (97.50)	1 (2.50)
	41–50	19 (100.00)	0 (0.00)
	51–65	16 (100.00)	0 (0.00)
Sex	Male	78 (96.30)	3 (3.70)	0.917
	Female	23 (95.83)	1 (4.17)
Alcohol use	Yes	43 (97.73)	1 (2.27)	0.717
	No	55 (96.49)	2 (3.51)
Smokes cigarette	Yes	19 (95.00)	1 (5.00)	0.773
	No	80 (96.39)	3 (3.61)
Reported substance use	Yes	8 (88.89)	1 (11.11)	0.245
	No	90 (96.77)	3 (3.23)

^aChi‐square test (Significant).